Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating activities:
Net income (loss)	$ (147,731)	$ (3,622)
Reconciliation of net income (loss) to cash provided by (used in) operating activities:
Depreciation, amortization, and accretion	33,606	38,342
Impairments of long-lived assets	10,670	0
Impairment of goodwill	106,205	0
Provision (benefit) for deferred income taxes	333	122
Equity-based compensation expense	2,373	1,596
Provision for doubtful accounts	198	242
Excess decommissioning and abandoning costs	37	152
Amortization of deferred financing costs	1,110	907
Other non-cash charges and credits	(593)	(1,390)
Gain on sale of assets	(1,019)	(1,650)
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	74,328	32,698
Inventories	(15,042)	(12,637)
Prepaid expenses and other current assets	(1,650)	773
Trade accounts payable and accrued expenses	(33,176)	(26,310)
Decommissioning liabilities, net	(3,379)	(566)
Other	(1,009)	(842)
Net cash provided by (used in) operating activities	25,261	27,815
Investing activities:
Purchases of property, plant, and equipment	(3,231)	(49,024)
Proceeds on sale of property, plant, and equipment	1,246	2,886
Other investing activities	(7)	(211)
Net cash provided by (used in) investing activities	(1,992)	(46,349)
Financing activities:
Proceeds from long-term debt	117,600	51,954
Principal payments on long-term debt	(130,951)	(37,329)
CSI Compressco LP distributions	(7,209)	(9,274)
Proceeds from exercise of stock options	28	285
Excess tax benefit from equity compensation	0	0
Other financing activities	(6)	0
Net cash provided by (used in) financing activities	(20,538)	5,636
Effect of exchange rate changes on cash	45	(970)
Decrease in cash and cash equivalents	2,776	(13,868)
Cash and cash equivalents at beginning of period	23,057	48,384
Cash and cash equivalents at end of period	25,833	34,516
Supplemental cash flow information:
Interest paid	19,822	16,358
Income taxes paid	$ 740	$ 2,923